Mounjaro (tirzepatide)

Mounjaro is tirzepatide, and it is the one genuine mechanistic departure in this class. Every other product acts on the GLP-1 receptor alone; tirzepatide also activates the receptor for a second gut hormone, GIP.

How it works

It acts on the GLP-1 receptor and, unusually in this class, also on the receptor for a second gut hormone — glucose-dependent insulinotropic polypeptide, or GIP. Activating that receptor does three things at once: it amplifies insulin release when blood glucose is high, it slows the rate at which the stomach empties, and it changes appetite signalling in the brain.

Those three actions explain almost everything about the experience of taking it. The metabolic benefit comes from the first; the sense of eating less without deciding to comes from the third; and most of the side effects are the second one felt from the inside. The mechanism in full is here.

What sets it apart

In head-to-head trials the dual agonist produced larger average weight reductions than semaglutide. That is an average across a trial population, not a prediction about you — response varies widely, and the better trial number does not always translate into the better medicine for an individual.

Who it is for

Mounjaro is licensed for type 2 diabetes (and weight management in some regions). That licence is not a formality: it determines what your prescriber can lawfully prescribe it for, what a health system or insurer will fund, and which dose ceiling applies. Two products containing the same molecule can carry different licences, and that is usually the real difference between them.

Whether it suits you is a separate question, and one that depends on your medical history rather than on the product. The exclusions that come up most often are a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, pregnancy or planned pregnancy, and severe gastrointestinal disease. None of these can be assessed from a web page — they are the reason the first conversation happens with a clinician.

The dose ladder

Treatment starts below a working dose and climbs on a schedule. The starting dose is not a treatment dose — it exists so the gut can adapt.

Maintenance: 5 mg, 10 mg or 15 mg weekly. 7.5 mg and 12.5 mg are stepping stones. The full schedule, with what each rung is for, is here.

What the first months look like

Mounjaro reaches a stable blood level in about 25 days, which is why the early weeks so often feel like nothing is happening. They are not a failure of the medicine; they are the medicine still arriving.

• Month one. Blood levels climbing toward their plateau on a starting dose that is not expected to do much. Side effects, if they appear, cluster in the days after each increase.
• Months two and three. The first genuinely therapeutic doses. This is usually where appetite change becomes unmistakable rather than ambiguous.
• Beyond. Either continued escalation or settling at a dose that works. Both are legitimate destinations; the top of the ladder is a ceiling, not a target.

Side effects, in outline

The gastrointestinal profile is broadly similar to semaglutide. The escalation has six rungs rather than five, which means more opportunities to pause — and pausing at a tolerable rung is a legitimate destination, not a stalled climb. The common effects — nausea, early fullness, constipation, reflux and fatigue — trace back to a stomach emptying more slowly, and they follow the dose ladder rather than appearing at random. The full picture, including the symptoms that are not side effects to wait out, is here.

Taking it

Once weekly, any day, with or without food. Single-dose pen or vial. Available strengths: 2.5, 5, 7.5, 10, 12.5 and 15 mg pens.

Because it is taken weekly, the routine that matters most is consistency — a fixed time you can keep to, and a way of recording that you did. The step-by-step routine is here, and the rule for a late dose is here.

Storage, in brief

Unopened: 2–8 °C. Once in use: 21 days (US label); some regional labels state 30 at up to 30 °C. Two clocks run — the printed expiry on an unopened product, and the in-use window that starts at first use and does not reset if the product goes back in the fridge. The detail, including travel, is here.

Stopping

Because Mounjaro clears over about 25 days rather than overnight, stopping is a gradual process whether or not you intend it to be. Appetite returns along that curve, which most people describe as something that crept up over weeks rather than an event.

That slow return is worth planning for. The window in which appetite is coming back but is not yet fully back is the window in which habits either hold or do not — and it is a much better time to have a plan than to improvise one. Stopping is also a decision to make with your prescriber rather than unilaterally, particularly where the medicine is treating diabetes rather than weight.

What it does not do

• It does not burn fat. There is no metabolic furnace being switched on. Weight changes because intake falls.
• It does not choose what you lose. Weight lost quickly, on low protein and without resistance training, includes a meaningful share of lean tissue. This is the most consequential under-discussed part of the treatment.
• It does not permanently retrain appetite. The effect is a response to a signal, and the signal stops when the medicine does.

How it compares

• Mounjaro vs Zepbound — Same molecule, same ladder, different label and different geography.
• Ozempic vs Mounjaro — The genuine comparison in this class: one hormone against two.
• Trulicity vs Mounjaro — Both from the same manufacturer, both weekly.

Mounjaro in detail

Common questions about Mounjaro

How long to reach 15 mg of Mounjaro?

Twenty-one weeks at the minimum pace — six rungs, at least four weeks each. But 15 mg is a maximum, not a target. 5 mg and 10 mg are both recognised maintenance doses and many people settle at one of them.

Are Mounjaro side effects worse than Ozempic?

Broadly comparable in kind and frequency. The escalation has six rungs rather than four, which means more increases but smaller relative jumps — and more places to pause if a step is hard.

I am five days late for Mounjaro. Now what?

Five days is outside the four-day window. Skip that dose and take your next one on the usual day. Do not take it late and then take the scheduled one three days later.

How long can Mounjaro stay out of the fridge?

Regional labels differ, so check the leaflet in your own box rather than a number quoted online. Whatever the figure, the clock starts when the pen leaves refrigeration and does not reset if you put it back.

Do I need to change the needle on a Mounjaro pen?

The single-dose pen has its needle built in and is discarded after use — there is nothing to change. If you have been supplied vials instead, the dose is drawn with a fresh syringe each time.